Effects of dual blockade of renin-angiotensin system on concentric left ventricular hypertrophy in essential hypertension: A randomized, controlled pilot study

American Journal of Hypertension

Volumn 21, Issue 2, 2008, Pages 231-237

  Grandi, Anna M ^a   Solbiati, Francesco ^a   Laurita, Emanuela ^a   Maresca, Andrea M ^a   Nicolini, Eleonora ^a   Marchesi, Chiara ^a   Gianni, Monica ^a   Guasti, Luigina ^a   Venco, Achille ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; LERCANIDIPINE; RAMIPRIL;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; HUMAN; HYPERTENSION; LABORATORY TEST; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BENZIMIDAZOLES; BLOOD PRESSURE; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; PILOT PROJECTS; RAMIPRIL; RENIN-ANGIOTENSIN SYSTEM; TETRAZOLES; TREATMENT OUTCOME;

EID: 38949092516     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1038/ajh.2007.47     Document Type: Article

References (32)

1. Weber KT. Cardioreparation in hypertensive heart disease. Hypertension 2001; 38:588-591.
2. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: part II. Causal mechanisms and treatment. Circulation 2002; 105:1503-1508.
3. Weber KT. Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation 1997; 96:4065-4082.
4. Varo N, Etayo J, Zalba G, Monrea LI, Diez J. Losartan inhibits the post-transcriptional synthesis of collagen type I and reverse left ventricular fibrosis in spontaneously hypertensive rats. J Hypertens 1997; 17:107-114.
5. Grandi AM, Venco A, Barzizza F, Casadei B, Marchesi E, Finardi G. Effect of enalapril on left ventricular mass and performance in essential hypertension. Am J Cardiol 1989; 63:1093-1097.
6. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: a meta-analysis of 109 treatment studies. Am J Hypertens 1992; 5:95-110.
7. Schmieder RE, Martus P, Klingbeil AU. Reversal of left ventricular hypertrophy in essential hypertension: a meta-analysis of randomized double-blind studies. JAMA 1996; 275:1507-1513.
8. Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 2000; 102:1388-1393.
9. Mathew J, Sleight P, Lonn E, Johnstone D, Pogue J, Yi Q, Bosch J, Sussex B, Probstfield J, Yusuf S. Heart Outcomes Prevention Evaluation (HOPE) Investigators. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 2001; 104:1615-1621.
10. Grandi AM, Bignotti M, Gaudio G, Zanzi P, Guasti L, Venco A. Ambulatory blood pressure and left ventricular changes during antihypertensive treatment: perindopril versus isradipine. J Cardiovasc Pharmacol 1995; 26:737-741.
11. Wachtell K, Bella JN, Rokkedal J, Palmieri V, Papademetriou V, Dalhof B, Aalto T, Gerdts E, Devereux RB. Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Circulation 2002; 105:1071-1076.
12. Klingbeil A, Schneider M, Martus P, Messerli FH, Schmieder RE. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension. Am J Med 2003; 115:41-46.
13. Juillerat L, Nussberger J, Ménard J, Mooser V, Christen Y, Waeber B, Graf P, Brunner HR. Determinants of angiotensin II generation during converting enzyme inhibition. Hypertension 1990; 16:564-572.
14. Sato A, Saruta T. Aldosterone breakthrough during angiotensin-converting enzyme inhibitor therapy. Am J Hypertens 2003; 16:781-788.
15. Doulton TW, He FJ, Mac Gregor GA. Systematic review of combined angiotensin-converting enzyme inhibition and Angiotensin receptor blockade in hypertension. Hypertension 2005; 45:880-886.
16. Sengul AM, Altuntas Y, Kurklu A, Aydin L. Beneficial effect of lisinopril plus telmisartan in patients with type 2 diabetes, microalbuminuria and hypertension. Diabetes Res Clin Pract 2006; 71:210-219.
17. van de Wal RMA, van Veldhuisen DJ, van Gilst WH, Voors AA. Addition of an angiotensin receptor blocker to full-dose ACE-inhibition: controversial or common sense ? Eur Heart J 2005; 26:2361-2367.
18. Koh KK, Quon MJ, Lee Y, Han SH, Ahn JY, Chung W, Kim J, Shin EK. Additive beneficial cardiovascular and metabolic effects of combination therapy with ramipril and candesartan in hypertensive patients. Eur Heart J 2007; 28:1440-1447.
19. Anan F, Takahashi N, Ooie T, Yufu K, Hara M, Nakagawa M, Yonemochi H, Saikawa T, Yoshimatsu H. Effects of valsartan and perindopril combination therapy on left ventricular hypertrophy and aortic arterial stiffness in patients with essential hypertension. Eur J Clin Pharmacol 2005; 61:353-359.
20. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Steward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7:79-108.
21. Upton MT, Gibson DG. The study of left ventricular function from digitized echocardiograms. Prog Cardiovasc Dis 1978; 20:359-384.
22. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: validation of the method. Circulation 1977; 55:613-618.
23. de Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Alderman MH, Laragh JH. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol 1994; 23:1444-1451.
24. Lee CH, Hogan JC, Gibson DG. Diastolic disease in left ventricular hypertrophy: comparison of M-mode and Doppler echocardiography for the assessment of rapid ventricular filling. Br Heart J 1991; 65:194-200.
25. Rakowski H, Appleton C, Chan KL, Dumesnil JG, Honos G, Jue J, Koilpillai C, Lepage S, Martin RP, Mercier LA, O'Kelly B, Prieur T, Sanfilippo A, Sasson Z, Alvarez N, Pruitt R, Thompson C, Tomlinson C. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the Investigators of Consensus on Diastolic Dysfunction by Echocardiography. J Am Soc Echocardiogr 1996; 9:736-760.
26. Brutsaert DL, Rademakers FE, Sys SU, Gillebert TC, Housmans PR. Analysis of relaxation in the evaluation of ventricular function of the heart. Prog Cardiovasc Dis 1985; 28:143-163.
27. Alpert MA, Lambert CR, Terry BE, Kelly DL, Panayiotou H, Mukerji V, Massey CV, Cohen MV. Effect of weight loss on left ventricular mass in non hypertensive morbidly obese patients. Am J Cardiol 1994; 73:918-921.
28. Grandi AM, Imperiale D, Santillo R, Barlocco E, Bertolini A, Guasti L, Venco A. Aldosterone antagonist improves diastolic function in essential hypertension. Hypertension 2002; 40:647-652.
29. Kim S, Yoshiyama M, Izumi Y, Kawano H, Kimono M, Zhan Y, Iwao H. Effects of combination of ACE inhibitor and angiotensin receptor blocker on cardiac remodelling, cardiac function, and survival in rat heart failure. Circulation 2001; 103:148-154.
30. Yoshida J, Yamamoto K, Mano T, Sakata Y, Nishikawa N, Nishio M, Ohtani T, Miwa T, Hori H, Masuyama T. AT1 receptor blocker added to ACE inhibitor provides benefits at advanced stage of hypertensive diastolic heart-failure. Hypertension 2004; 43:686-691.
31. The CAFÉ investigators for the Anglo-Scandinavian Cardiac Outcomes trial (ASCOT) Investigators. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Principal results of the Conduit Artery Function Evaluation (CAFÉ) Study. Circulation 2006; 113:1213-1225.
32. Takazawa K, Kobayashi H, Shindo N, Tanaka N, Yamashina A. Relationship between radial and central arterial pulse wave and evaluation of central aortic pressure using the radial arterial pulse wave. Hypertens Res 2007; 30:219-228.